Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jingju Wu
Observed names:
J. Wu,
Jian‐Nong Wu
Institutions:
Zhejiang Chinese Medical University,
Zhejiang Provincial Hospital of TCM,
Second Affiliated Hospital of Fujian Medical University
Observed institutions:
Zhejiang Chinese Medical University,
Zhejiang Provincial Hospital of TCM,
Second Affiliated Hospital of Fujian Medical University
ORCID:
0009-0008-7526-7785
Observed ORCID:
0009-0008-7526-7785
OpenAlex ID:
A5069938348
Mechanisms of rifaximin inhibition of hepatic fibrosis in mice with metabolic dysfunction associated steatohepatitis through the TLR4/NFκB pathway
2025
·
Ting Qiu
, Xiaodong Zhu
, et al.
·
Scientific Reports
·
18
β-elemene alleviates esophageal fibrosis after endoscopic submucosal dissection via the FAP-mediated PTEN-PI3K/AKT signaling pathway
2024
·
Jingju Wu
, Caifa Hong
, et al.
·
Heliyon
·
3
Monitoring of serum markers for fibrosis during CCL4-induced liver damage. Effects of anti-fibrotic agents
1991
·
J. Wu
, Z. Jian
, et al.
·
Journal of Hepatology
·
3
Enhancing HF ‐ DL Model Validation for Liver Fibrosis Staging Through Sample Optimisation and Technical Integration
2025
·
Meng‐Yuan Shen
, Ze‐Jiong Li
, et al.
·
Liver International
PDF
Show more works
View as search
Works count:
4
Citation count:
24
H-index:
3
I10-index:
1
Year
Topic
Type